• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由新冠病毒感染或新冠疫苗接种诱导产生的中和抗体所识别的表位之间的差异。

Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination.

作者信息

Yamamoto Shinya, Yamayoshi Seiya, Ito Mutsumi, Sakai-Tagawa Yuko, Nakachi Ichiro, Baba Rie, Kamimoto Shigenobu, Ogura Takayuki, Hagiwara Shigehiro, Kato Hideaki, Nakajima Hideaki, Uwamino Yoshifumi, Yagi Kazuma, Sugaya Norio, Nagai Hiroyuki, Saito Makoto, Adachi Eisuke, Koga Michiko, Tsutsumi Takeya, Duong Calvin, Okuda Moe, Murakami Jurika, Furusawa Yuri, Ujie Michiko, Iwatsuki-Horimoto Kiyoko, Yotsuyanagi Hiroshi, Kawaoka Yoshihiro

机构信息

Division of Virology, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.

Division of Infectious Diseases, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.

出版信息

iScience. 2023 Jun 25;26(7):107208. doi: 10.1016/j.isci.2023.107208. eCollection 2023 Jul 21.

DOI:10.1016/j.isci.2023.107208
PMID:37448563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10290734/
Abstract

SARS-CoV-2 has gradually acquired amino acid substitutions in its S protein that reduce the potency of neutralizing antibodies, leading to decreased vaccine efficacy. Here, we attempted to obtain mutant viruses by passaging SARS-CoV-2 in the presence of plasma samples from convalescent patients or vaccinees to determine which amino acid substitutions affect the antigenicity of SARS-CoV-2. Several amino acid substitutions in the S2 region, as well as the N-terminal domain (NTD) and receptor-binding domain (RBD), affected the neutralization potency of plasma samples collected from vaccinees, indicating that amino acid substitutions in the S2 region as well as those in the NTD and RBD affect neutralization by vaccine-induced antibodies. Furthermore, the neutralizing potency of vaccinee plasma samples against mutant viruses we obtained or circulating viruses differed among individuals. These findings suggest that genetic backgrounds of vaccinees influence the recognition of neutralizing epitopes.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的刺突(S)蛋白已逐渐发生氨基酸替换,降低了中和抗体的效力,导致疫苗效力下降。在此,我们试图通过在康复患者或疫苗接种者的血浆样本存在的情况下传代SARS-CoV-2来获得突变病毒,以确定哪些氨基酸替换会影响SARS-CoV-2的抗原性。S2区域以及N端结构域(NTD)和受体结合结构域(RBD)中的几个氨基酸替换影响了从疫苗接种者收集的血浆样本的中和效力,表明S2区域以及NTD和RBD中的氨基酸替换会影响疫苗诱导抗体的中和作用。此外,疫苗接种者血浆样本对我们获得的突变病毒或流行病毒的中和效力在个体之间存在差异。这些发现表明,疫苗接种者的遗传背景会影响中和表位的识别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/d273cddf7e97/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/2e9d96a5bc8d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/b62126df9883/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/7e7178c16464/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/ddf2156787dd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/d273cddf7e97/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/2e9d96a5bc8d/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/b62126df9883/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/7e7178c16464/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/ddf2156787dd/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f52/10339179/d273cddf7e97/gr4.jpg

相似文献

1
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination.由新冠病毒感染或新冠疫苗接种诱导产生的中和抗体所识别的表位之间的差异。
iScience. 2023 Jun 25;26(7):107208. doi: 10.1016/j.isci.2023.107208. eCollection 2023 Jul 21.
2
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.免疫功能低下宿主接受恢复期血浆治疗后出现多种 SARS-CoV-2 抗体逃逸变异体。
mSphere. 2021 Aug 25;6(4):e0048021. doi: 10.1128/mSphere.00480-21.
3
Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals.接种疫苗人群中 SARS-CoV-2 病毒中和抗体滴度与刺突抗体和 ACE2 抑制的相关性。
Microbiol Spectr. 2022 Oct 26;10(5):e0131522. doi: 10.1128/spectrum.01315-22. Epub 2022 Sep 19.
4
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
5
Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.新型冠状病毒刺突蛋白受体结合域中新型中和表位的鉴定与表征:揭示灭活新型冠状病毒疫苗中的关键抗原决定簇
Vaccine. 2006 Jun 29;24(26):5498-508. doi: 10.1016/j.vaccine.2006.04.054. Epub 2006 May 11.
6
Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors.新型冠状病毒肺炎幸存者中针对 SARS-CoV-2 刺突蛋白结构域的中和抗体和结合抗体的动态变化。
Viral Immunol. 2022 Oct;35(8):545-552. doi: 10.1089/vim.2022.0059. Epub 2022 Oct 3.
7
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination.一种新型的 HXP-S 新冠病毒灭活疫苗在人体中诱导产生的中和抗体比例高于 mRNA 疫苗。
Sci Transl Med. 2023 Feb 15;15(683):eabo2847. doi: 10.1126/scitranslmed.abo2847.
8
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma.新冠康复期血浆中对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)非受体结合域(RBD)刺突蛋白表位的普遍、保护性和趋同IgG识别
bioRxiv. 2020 Dec 21:2020.12.20.423708. doi: 10.1101/2020.12.20.423708.
9
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
10
Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization.对 Gam-COVID-Vac 疫苗接种者的抗体反应进行分析,提示 S 蛋白受体结合域(RBD)以外的表位在新冠病毒中和中发挥作用。
Int J Mol Sci. 2023 Mar 7;24(6):5104. doi: 10.3390/ijms24065104.

本文引用的文献

1
Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies.免疫球蛋白胚系基因多态性影响 SARS-CoV-2 中和抗体的功能。
Immunity. 2023 Jan 10;56(1):193-206.e7. doi: 10.1016/j.immuni.2022.12.005. Epub 2022 Dec 12.
2
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.啮齿动物中新型冠状病毒奥密克戎BA.4和BA.5毒株的特征分析
Nature. 2022 Dec;612(7940):540-545. doi: 10.1038/s41586-022-05482-7. Epub 2022 Nov 2.
3
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection.
接种三剂 BioNTech 或科兴疫苗、自然感染和突破性感染后,针对 BA.2.12.1、BA.4 和 BA.5 的斑块中和抗体。
J Clin Virol. 2022 Nov;156:105273. doi: 10.1016/j.jcv.2022.105273. Epub 2022 Aug 31.
4
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.奥密克戎 BA.2 型 SARS-CoV-2 的特征和抗病毒敏感性
Nature. 2022 Jul;607(7917):119-127. doi: 10.1038/s41586-022-04856-1. Epub 2022 May 16.
5
Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021.2021 年 1 月至 11 月,爱沙尼亚、爱尔兰、卢森堡和斯洛伐克的监测数据分析显示,接种疫苗的 COVID-19 病例的重症结局风险降低。
Euro Surveill. 2022 Feb;27(7). doi: 10.2807/1560-7917.ES.2022.27.7.2200060.
6
Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model.在仓鼠模型中,感染获得的针对 SARS-CoV-2 Delta 变体的长期免疫力。
Cell Rep. 2022 Feb 15;38(7):110394. doi: 10.1016/j.celrep.2022.110394. Epub 2022 Jan 31.
7
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.一种人类抗体揭示了β冠状病毒刺突蛋白上的一个保守位点,并赋予对SARS-CoV-2感染的保护作用。
Sci Transl Med. 2022 Mar 23;14(637):eabi9215. doi: 10.1126/scitranslmed.abi9215.
8
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape.在晚期 HIV 疾病中,SARS-CoV-2 持续感染会导致广泛的免疫逃逸。
Cell Host Microbe. 2022 Feb 9;30(2):154-162.e5. doi: 10.1016/j.chom.2022.01.005. Epub 2022 Jan 14.
9
Efficacy of Antibodies and Antiviral Drugs against Covid-19 Omicron Variant.抗体和抗病毒药物对新冠病毒奥密克戎变异株的疗效
N Engl J Med. 2022 Mar 10;386(10):995-998. doi: 10.1056/NEJMc2119407. Epub 2022 Jan 26.
10
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.